Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

Metabolic syndrome (MetS) is a constellation of cardiovascular risk factors that increases the risk of cardiovascular disease, diabetes mellitus, and all cause mortality. Long-term survivors of hematopoietic cell transplantation (HCT) have a substantial risk of developing MetS and cardiovascular dis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: DeFilipp, Zachariah, Duarte, Rafael F., Snowden, John A., Majhail, Navneet S., Greenfield, Diana M., Miranda, José López, Arat, Mutlu, Baker, K. Scott, Burns, Linda J., Duncan, Christine N., Gilleece, Maria, Hale, Gregory A., Hamadani, Mehdi, Hamilton, Betty K., Hogan, William J., Hsu, Jack W., Inamoto, Yoshihiro, Kamble, Rammurti T., Lupo-Stanghellini, Maria Teresa, Malone, Adriana K., McCarthy, Philip, Mohty, Mohamad, Norkin, Maxim, Paplham, Pamela, Ramanathan, Muthalagu, Richart, John M., Salooja, Nina, Schouten, Harry C., Schoemans, Helene, Seber, Adriana, Steinberg, Amir, Wirk, Baldeep M., Wood, William A., Battiwalla, Minoo, Flowers, Mary E.D., Savani, Bipin N., Shaw, Bronwen E.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4949101/
https://ncbi.nlm.nih.gov/pubmed/27184625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.05.007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars